MAZE Stock Analysis: Buy, Sell, or Hold?
MAZE - Maze Therapeutics, Inc. Common Stock
$43.58
-1.42 (-3.16%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Get Alerted When MAZE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MAZE shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: MAZE shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: MAZE is currently trading at $43.58, which is considered slightly high relative to its 30-day fair value range of $39.68 to $44.03.
Technical Outlook: Technically, MAZE is in a strong uptrend. Immediate support is located at $38.62, while resistance sits at $47.36. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: MAZE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MAZE is in a strong uptrend. Immediate support is located at $38.62, while resistance sits at $47.36. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: MAZE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$39.68 -
$44.03
Company Quality Score
61/100
(BUY)
Options IV Signal
24th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
75.0%
All Signals
- BULLISH: Options cheap (IV 24th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- NEUTRAL: Near Wall St target ($49.44)
Fair Price Analysis
30-Day Fair Range
$39.68 -
$44.03
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
±$5.24
(12.0%)
Support & Resistance Levels
Support Level
$38.62
Resistance Level
$47.36
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-14.30
Wall Street Target
$49.44
(+9.9%)
Last updated: January 31, 2026 11:22 AM ET
Data refreshes hourly during market hours. Next update: 12:22 PM
Data refreshes hourly during market hours. Next update: 12:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MAZE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Richard H Scheller
SELL
20744 shares
2025-09-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced MAZE Option Strategies
Professional options setups generated by AI based on today's MAZE price and gamma walls.
